|
|
|
Cr Bob's Newsletter - December, 2004
------------Topics----------- #1 Don't Ignore High Blood Pressure - Do You Know Yours? #2 Anti-Oxidants, An Update #3 Baby Teeth -Pacifiers and Thumb Sucking #4 Tablet Splitting #5Grape Juice and Cholesterol High Blood Pressure...
Medical question #2. Ovarian cysts. Part2
Polycystic ovarian syndrome is a little bit different animal actually. Here is some genetic predisposition. Classically: an overweight young female presents with oligomenorrhea or amenorrhea, anovulation, acne, hirsutism, and or infertility. ...
NaProTechnology In The Ovulation Toolbox
NaProTechnology is a new approach in obstetrics and gynecology based on the Ovulation Method of Natural Family Planning (NFP). With this revolutionary new approach of understanding and treating the menstrual cycle, we have new ways of addressing...
Rubber band bracelets: be in the loop
Those colorful loops of rubber should be quite familiar to you by now. Yes, we are talking about rubber band bracelets. They have become ubiquitous in the last couple of years. You can see them on the wrists of Tsunami aid workers, citizens...
Women's Health Care: The Top Health Care Issues Women Face Today
When the topic of women's health care is raised, the first
disease that comes to mind is probably breast cancer. But
surprisingly, that's not the number one health care issue
confronting women today. In fact, heart disease kills more women
each...
|
|
| |
|
|
|
|
|
|
Ultrasound Therapeutics Ltd brings radical new Chinese cancer treatment to the Western World
Thanks to recent European approval (CE Mark) thousands of liver and kidney cancer sufferers across the World could now benefit from a remarkable piece of proven medical technology from China.
Since 1997 the model-JC Tumour Therapy System (Chongqing HaifuTM Technology Co, China) has successfully treated over 8,000 patients with a variety of cancers at over 20 centres in the Far East. Supported by successful clinical trials performed at The Churchill Hospital in Oxford, UK - funded by UK based company, Ultrasound Therapeutics Ltd - the equipment has recently been awarded CE approval certification, the first major therapeutic device from China to have gained CE approval. The granting of this stringent European qualification could now mean new hope for cancer patients seeking effective tumour treatment in the West.
Whilst diagnostic ultrasound scans will be familiar to thousands of pregnant women, High-Intensity Focused Ultrasound (HIFU) concentrates the energy to a very small focal point. These focused waves have the ability to literally 'cook' tumours without the need for potentially hazardous open surgery.
The process requires no incision and also has the added benefit of minimal toxicity unlike chemo or radiotherapy. However, in some cases, there is no reason why the process cannot be used in conjunction with other established cancer treatments.
The model-JC Tumour Therapy System focuses ultrasound waves inside the body and the point of focus is 'aimed' by the operator using ultrasound imaging techniques. This allows the doctors operating the machine to guide the focus directly in to the tumour without any damage to the surrounding tissue.
In order to keep the patient perfectly still throughout, the procedure is carried out under general anaesthetic.
In terms of side effects, the only post-treatment discomfort observed were tiny and insignificant skin blisters and a small number of patients needed little more than mild pain relief the following day. This information only serves to corroborate the experience reported from China and the Far East.
The Churchill trials show successful targeted focal ablation in 95% of treated liver tumours and, in the most recent trials, kidney tumours have also been successfully treated. The centre is still undertaking further trials but is also able to consider off-trial referrals as appropriate.
It must be noted that all referrals will be discussed in detail with local oncologists to ensure feasibility and practicality of all potential treatments.
Recent publications in respected journals also show benefits to patients with pancreatic, breast and some bone cancers.
Ultrasound Therapeutics Ltd
Ultrasound Therapeutics Ltd has pioneered and funded the HIFU process in the Western World and is currently investigating HIFU's enormous potential in several other areas of medicine for both benign and malignant conditions.
The Stockport-based firm is a private company funded by its shareholders.
www.utlltd.com for pictures and text downloads
For sales information please contact David Wild on +44 (0) 161 477 6111
or email davidwild@utlltd.com
For media information please contact Mark Forsyth on +44 (0) 7721 009041
or email press@utlltd.com
Patient enquiry number: 0871 2300424
About the Author
Press Department @ UTL
|
|
|
|
|
|